Suchergebnisse - "Hu, Huabin"

PubPharm (156)

31

mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer : A Propensity Score Matching Analysis

enthalten in: Clinical colorectal cancer | 2022

von Ding, M. | Zhang, J. | Hu, H. | +7

32

Systematic identification of activity cliffs with dual-atom replacements and their rationalization on the basis of single-atom replacement analogs and X-ray structures

enthalten in: Chemical biology & drug design | 2022

von Hu, H. | Bajorath, J.

33

Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related Compounds

enthalten in: Journal of medicinal chemistry | 2022

von Laufkötter, O. | Hu, H. | Miljković, F. | +1

34

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC) : a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Hu, H. | Kang, L. | Zhang, J. | +27

CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):4-6. - PMID 34688372

35

A novel pentacyclic triterpene from the canes of Uncaria sessilifructus (Rubiaceae)

enthalten in: Natural product research | 2022

von Fan, Q. | Na, Z. | Ji, K. | +6

36

A prognostic nomogram for intrahepatic progression-free survival in patients with colorectal liver metastases after ultrasound-guided percutaneous microwave ablation

enthalten in: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group | 2022

von Qin, S. | Hu, H. | Cui, R. | +5

37

Systematic identification of activity cliffs with dual‐atom replacements and their rationalization on the basis of single‐atom replacement analogs and X‐ray structures

enthalten in: Chemical Biology & Drug Design | 2022

von Hu, H. | Bajorath, J.

38

mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases : the FORBES non-randomized phase II trial

enthalten in: Annals of translational medicine | 2022

von Shen, C. | Hu, H. | Cai, Y. | +20

CommentIn: Ann Transl Med. 2022 Sep;10(18):952. - PMID 36267710

39

Mucinous Adenocarcinoma Predicts Poor Response and Prognosis in Patients With Locally Advanced Rectal Cancer : A Pooled Analysis of Individual Participant Data From 3 Prospective Studies

enthalten in: Clinical colorectal cancer | 2021

von Zhang, J. | Xie, X. | Wu, Z. | +7

40

First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer : a United States-based cost-effectiveness analysis

enthalten in: Cost effectiveness and resource allocation : C/E | 2021

von Zhu, Y. | Hu, H. | Ding, D. | +4